Zolpidem is a short-acting sleep medicine used for the short-term treatment of insomnia that is difficulty falling asleep or staying asleep. It works rapidly, helping most patients fall asleep within 15 to 30 minutes of taking the tablet. Zolpidem is classified as a Schedule H drug requiring a valid prescription.

Drug Class: Non-Benzodiazepine Hypnotic – What That Means

Zolpidem belongs to the class of medicines called non-benzodiazepine hypnotics also known as 'Z-drugs' which include zolpidem, zaleplon and zopiclone. Despite not being chemically a benzodiazepine, zolpidem works on the same GABA-A receptor as benzodiazepines, binding more selectively to the alpha-1 subunit responsible for sedation. This selectivity was originally thought to give Z-drugs a better safety profile, causing less amnesia, muscle relaxation and dependence but clinical experience has shown that the differences are modest and Z-drugs carry many of the same risks as benzodiazepines.

How Zolpidem Helps You Fall Asleep Faster

Insomnia involves a state of hyperarousal - the brain is too active and alert to transition smoothly into sleep. Zolpidem acts by binding to GABA-A receptors and enhancing the effect of GABA (the brain's main inhibitory neurotransmitter). By amplifying GABA's calming signal, zolpidem reduces neuronal activity in the regions responsible for arousal and wakefulness, rapidly reducing the time it takes to fall asleep (sleep onset latency) and in many patients increasing total sleep duration.

Medical Use

Zolpidem is approved exclusively for the short-term treatment of insomnia in adults - a maximum of 2 to 4 weeks, including the tapering period. Tolerance and dependence develop rapidly with regular use. Long-term use is associated with cognitive impairment, increased fall risk in elderly patients, rebound insomnia and dependence. The only evidence-based long-term treatment for chronic insomnia is cognitive behavioural therapy for insomnia (CBT-I).

Immediate Release vs Extended Release 

Key differences are:

• Immediate-release zolpidem (IR): The standard form in India; helps patients fall asleep quickly; available as 5 mg and 10 mg tablets; eliminated relatively quickly (half-life approximately 2 to 3 hours), reducing next-day sedation risk; effective for sleep onset difficulties but provides little help for middle-of-the-night awakenings

• Extended-release zolpidem (ER): A two-layer tablet releasing part of the dose immediately (for sleep onset) and part gradually (for sleep maintenance); available in 6.25 mg and 12.5 mg strengths; carries a higher risk of next-day sedation than the immediate-release form due to prolonged drug exposure.

Side Effects 

Common side effects are:

• Next-day drowsiness (residual sedation): Occurs when zolpidem has not fully cleared by morning; more common with the 10 mg dose, in women (who metabolise zolpidem more slowly than men), in elderly patients and when zolpidem is taken less than 7 to 8 hours before waking

• Anterograde amnesia: Memory impairment for events occurring after taking the tablet; patients may have no recollection of phone calls, conversations,or activities following zolpidem ingestion; more pronounced at higher doses and when the patient does not go to bed immediately

• Rebound insomnia: When zolpidem is stopped after regular use, sleep quality temporarily worsens below pre-treatment levels

• Headache, dizziness and nausea: Common at the start of treatment; dizziness increases the risk of falls particularly in elderly patients

Serious Risks

Zolpidem is associated with unusual and potentially dangerous behaviours during sleep that occur when the patient is pharmacologically sedated but not fully unconscious:

• Sleepwalking: Getting out of bed, moving around the home or going outdoors while asleep and unaware; zolpidem-induced sleepwalking can lead to falls, injuries and dangerous exposure to the environment

• Sleep driving: Patients have been reported driving vehicles while in a zolpidem-induced sleep state with no memory of the event

• Hallucinations: Vivid, often frightening visual or auditory hallucinations, particularly in the hypnagogic (falling asleep) state; more common at higher doses.

Dependency and Withdrawal – Risks of Prolonged Use

The risk of physical dependence on zolpidem is real and clinically important. Within 2 to 4 weeks of regular use, many patients develop tolerance (the drug becomes less effective at the same dose) and physical dependence (stopping abruptly causes withdrawal symptoms). 

Withdrawal symptoms include insomnia (often worse than before starting the drug), anxiety, irritability, sweating, tremors and palpitations and in severe cases withdrawal can cause seizures. Rebound insomnia is a predictable withdrawal phenomenon that resolves within a few days but often leads patients to continue the drug, perpetuating dependence.

Tapering - the dose should be reduced gradually over several weeks (typically 25% every 1 to 2 weeks) under medical supervision. Cognitive behavioural therapy for insomnia (CBT-I) is the recommended alternative to continued zolpidem use.

Who Should Not Take Zolpidem?

• Patients with severe sleep apnoea: Zolpidem suppresses respiratory drive and can worsen nocturnal hypoxia

• Patients with severe hepatic impairment: Severe hepatic impairment leads to dangerous drug accumulation and prolonged sedation

• Patients with a prior history of complex sleep behaviours on any sedative: The risk of recurrence is high and the consequences dangerous

• Patients with a history of alcohol or drug misuse: The risk of dependence and misuse is significantly higher

• Pregnant women: Zolpidem crosses the placenta and can cause neonatal respiratory depression, hypotonia, and neonatal withdrawal syndrome.

Drug Interactions

Key interactions are:

• Alcohol 

• Anticonvulsants

• Antidepressants (particularly sedating TCAs)

• Antihistamines like chlorphenamine, promethazine

• Antipsychotics

• Anxiolytics

• CYP3A4 inhibitors like ketoconazole, itraconazole, clarithromycin, erythromycin

• Opioids like tramadol, codeine, morphine, buprenorphine.

Zolpidem vs Melatonin vs Antihistamines for Sleep

Main differences are:

• Mechanism: Zolpidem enhances GABA-mediated inhibition, producing pharmacological sedation; melatonin is a hormone that signals to the brain's circadian clock that it is night-time; antihistamines cause sedation as a side effect of H1 receptor blockade in the brain

• Efficacy: Zolpidem is the most potent for acute insomnia, reliably reducing sleep onset latency; melatonin is best suited for circadian rhythm disorders (jet lag, delayed sleep phase) not primary insomnia; antihistamines develop tolerance within 3 to 4 days, making them ineffective for ongoing insomnia

• Safety: Melatonin has no significant dependence risk, no next-day sedation at standard doses and no complex sleep behaviours; antihistamines can cause next-day sedation, anticholinergic side effects and cognitive impairment; zolpidem carries the highest risk of dependence, complex sleep behaviours and next-day sedation of the three.

FAQs

1. What is zolpidem tablet used for?

   Zolpidem tablets are used for the short-term treatment of insomnia in adults for a maximum of 2 to 4 weeks. It is a Schedule H drug requiring a prescription.

2. How quickly does zolpidem make you fall asleep?

   Zolpidem acts rapidly and most patients begin to feel sleepy within 15 to 30 minutes and are asleep within 30 to 60 minutes. Zolpidem should be taken immediately before going to bed, because taking it and then staying awake significantly increases the risk of next-day amnesia and complex sleep behaviours such as sleepwalking.

3. Can zolpidem cause sleepwalking or unusual behaviour during sleep?

   Yes zolpidem is associated with unusual behaviours during sleep, including sleepwalking, sleep driving, sleep eating and sleep conversations, which occur when the patient is pharmacologically sedated but not in full normal sleep. The patient typically has no memory of them. They are more common at higher doses and when zolpidem is combined with alcohol. If any of these behaviours occur, zolpidem should be stopped immediately.

4. Is zolpidem addictive?

   Zolpidem carries a significant risk of physical dependence particularly when used for longer than 2 to 4 weeks. The body adapts to the presence of zolpidem and the patient experiences withdrawal symptoms (rebound insomnia, anxiety, tremors) when the drug is stopped. Some patients also develop psychological dependence - a strong belief that they cannot sleep without the drug.

5. What happens if zolpidem is taken with alcohol?

   Taking zolpidem with alcohol is dangerous and must be avoided. Combining even a small amount of alcohol with zolpidem can cause severe sedation, respiratory depression, amnesia for events during the night and dramatically increased risk of complex sleep behaviours including sleep driving. Patients should not drink alcohol on any evening they plan to take zolpidem.

6. How long should zolpidem be taken for insomnia?

   Zolpidem is approved for a maximum of 2 to 4 weeks. Beyond this period, tolerance and dependence develop rapidly and the risks of long-term use like cognitive impairment, fall risk, rebound insomnia and dependence outweigh the benefits. For persistent insomnia, cognitive behavioural therapy for insomnia (CBT-I) is the recommended first-line treatment.

7. Can zolpidem cause memory problems the next morning?

   Yes zolpidem can cause anterograde amnesia (inability to form new memories after taking the tablet). Patients may have no recollection of phone calls, conversations or activities following zolpidem ingestion. The risk is highest at the 10 mg dose, when the patient does not go to bed immediately and when zolpidem is combined with alcohol or other sedatives.

8. Is zolpidem safe for elderly patients?

   Zolpidem should be used with great caution in elderly patients. In elderly patients zolpidem is eliminated more slowly, leading to drug accumulation, prolonged sedation and increased fall risk. If used in an elderly patient, the dose should be halved and treatment kept as brief as possible.

9. What is the difference between zolpidem and diazepam for sleep?

   Both zolpidem and diazepam enhance GABA-mediated inhibition to produce sedation but they differ in several important ways. Zolpidem has a shorter half-life (2 to 3 hours versus 20 to 100 hours for diazepam), reducing next-day sedation. Diazepam also produces muscle relaxation, anticonvulsant effects and anxiolysis - effects that zolpidem lacks. Diazepam's much longer duration of action makes it more suitable for anxiety and alcohol withdrawal.

10. Can zolpidem be stopped suddenly or does it need tapering?

    Zolpidem should not be stopped suddenly after regular use as abrupt discontinuation can cause rebound insomnia, anxiety, irritability, sweating and tremors and at high doses or after prolonged use withdrawal can cause seizures. The dose should be reduced gradually over several weeks (typically 25% every 1 to 2 weeks) under medical supervision. CBT-I should be introduced during the tapering process.

References

1. Greenblatt DJ, Roth T. Zolpidem for insomnia. Expert Opin Pharmacother. 2012;13(6):879–93. https://doi.org/10.1517/14656566.2012.667074

2. Kripke DF. Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit. F1000Res. 2016;5:918. https://doi.org/10.12688/f1000research.8729.3

3. US Food and Drug Administration. FDA drug safety communication: FDA requires lower recommended doses for certain sleep drugs containing zolpidem. FDA. 2013. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-requires-lower-recommended-doses-certain-sleep-drugs-containing

4. Trauer JM, Qian MY, Doyle JS, Rajaratnam SM, Cunnington D. Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis. Ann Intern Med. 2015;163(3):191–204. https://doi.org/10.7326/M14-2841

5. Gunja N. The clinical and forensic toxicology of Z-drugs. J Med Toxicol. 2013;9(2):155–62. https://doi.org/10.1007/s13181-013-0295-x